p38 mitogen-activated protein kinase plays a critical role in the control of energy metabolism and development of cardiovascular diseases

Journal of Central South University (Medical Sciences)

Volumn 32, Issue 1, 2007, Pages 1-14

  Cao, Wen Hong ^a,b   Xiong, Yan ^a,c   Collins, Qu Fan ^a   Liu, Hui Yu ^a  

^a HAMNER INSTITUTES FOR HEALTH SCIENCES   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Adipocyte; Apoptosis; Diabetes; Gluconeogenesis; Glucose transporter 4 (Glut 4); Glucose uptake; Insulin secretion; Insulin signaling; Obesity; p38; Phosphoenolpyruvate carboxykinase (PEPCK); Skeletal muscle; Uncoupling protein 1 (UCP1)

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38;

ADIPOSE TISSUE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; ENERGY METABOLISM; ENZYMOLOGY; HUMAN; METABOLISM; PANCREAS ISLET BETA CELL; PHYSIOLOGY; REVIEW; SKELETAL MUSCLE;

ADIPOSE TISSUE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; ENERGY METABOLISM; HUMANS; INSULIN-SECRETING CELLS; MUSCLE, SKELETAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 33947579564     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (156)

1. Ono K, Han J. The p38 signal transduction pathway; activation and function[J]. Cell Signal, 2000,12(1):1-13.
2. Cao W, Medvedev A V, Daniel KW, et al. beta-Adrenergic activation of p38 MAP kinase in adipocytes: cAMP induction of the uncoupling protein 1 (UCP1) gene requires p38 MAP kinase[J]. J Biol Chem, 2001,276(29):27077-27082.
3. Cao W, Daniel K W, Robidoux J, et al. p38 mitogen-activated protein kinase is the central regulator of cyclic AMP-dependent transcription of the brown fat uncoupling protein 1 gene[J]. Mol Cell Biol, 2004,24(7):3057-3067.
4. Robidoux J, Cao W, Quan H, et al. Selective activation of MAP kinase kinase-3 and p38 MAP kinase is essential for cAMP-dependent UCP1 expression in adipocytes[J]. Mol Cell Biol, 2005, 25(13):5466-5479.
5. Cao W, Collins Q F, Becker T C, et al. p38 mitogen-activated protein kinase plays a stimulatory role in hepatic gluconeogenesis [J]. J Biol Chem, 2005,280(52):42731-42737.
6. Srinivasan S, Bolick D T, Hatley M E, et al. Glucose regulates interleukin-8 production in aortic endothelial cells through activation of the p38 mitogen-activated protein kinase pathway in diabetes [J]. J Biol Chem, 2004,279(30):31930-31936.
7. Nakagami H, Morishita R, Yamamoto K, et al. Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D-glucose in human endothelial cells[J]. Diabetes, 2001,50(6):1472-1481.
8. Kuki S, Imanishi T, Kobayashi K, et al. Hyperglycemia accelerated endothelial progenitor cell eenescence via the activation of p38 mitogen-activated protein kinase [J]. Circ J, 2006,70 (8):1076-1081.
9. Wang X L, Zhang L, Youker K, et al. Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase[J]. Diabetes, 2006,55(8):2301-2310.
10. Collins Q F, Xiong Y, Lupo J, et al. p38 mitogen-activated protein kinase mediates free fatty acid-induced gluconeogenesis in hepatocytes[J]. J Biol Chem, 2006 281 (34):24336-24344.
11. Mora S, Pessin J E. An adipocentric view of signaling and intracellular trafficking[J]. Diabetes Metab Res Rev, 2002,18(5):345-356.
12. Trayhurn P. Endocrine and signalling role of adipose tissue: new perspectives on fat[J]. Acta Physiol Scand, 2005,184(4):285-293.
13. Cohen P, Friedman J M. Leptin and the control of metabolism: role for stearoyl-CoA desaturase-1 (SCD-1)[J]. J Nutr, 2004,134 (9):2455S-2463S.
14. Nedergaard J, Cannon B. Brown Adipose Tissue: Development and Function[M]. Second ed. W. B. Saunders Company, Philadelphia, London, Toronto, Montreal, Sydney, Tokyo, 1998:478-489.
15. Collins S, Cao W H, Dixon TM, et al. Body weight regulation, uncoupling proteins and energy metabolism[M]. Moustaid-Moussa N, Berdanier C (eds) Nutrition and Gene Expression, CRC Press,2001.
16. Florez-Duquet M, McDonald R B. Cold-induced thermoregulation and biological aging[J]. Physiol Rev, 1998,78(2):339-358.
17. 3-agonist, on energy balance and brown and white adipose tissues in rats[J]. Am J Physiol, 1994,266 (4 Pt 2):R1371-R1382.
18. Collins S, Daniel K W, Petro A E, et al. Strain-specific response to beta 3-adrenergic receptor agonist treatment of diet-induced obesity in mice[J]. Endocrinology, 1997,138(1):405-413.
19. Sasaki N, Uchida E, Niiyama M, et al. Anti-obesity effects of selective agonists to the β3-adrenergic receptor in dogs[J]. II. Recruitment of thermogenic brown adipocytes and reduction of adiposity after chronic treatment with a β3-adrenergic agonist[J]. J Vet Med Sci, 1998,60(4):465-469.
20. Champigny O, Ricquier D, Blondel O, et al. β3-Adrenergic receptor stimulation restores message and expression of brown-fat mitochondrial uncoupling protein in adult dogs[J]. Proc Natl Acad Sci USA, 1991,88(23):10774-10777.
21. Fisher M H, Amend A M, Bach T J, et al. A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys[J]. J Clin Invest, 1998,101(11):2387-2393.
22. Engelman JA, Lisanti MP, Scherer PE. Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis[J]. J Biol Chem, 1998,273(48):32111-32120.
23. Takenouchi T, Takayama Y, Takezawa T. Co-treatment with dexamethasone and octanoate induces adipogenesis in 3T3-L1 cells[J]. Cell Biol Int, 2004,28(3):209-216.
24. Engelman J A, Berg A H, Lewis R Y, et al. Constitutively active mitogen-activated protein kinase kinase 6 (MKK6) or salicylate induces spontaneous 3T3-L1 adipogenesis[J]. J Biol Chem, 1999, 274(50):35630-35638.
25. Hata K, Nishimura R, Ikeda F, et al. Differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor gamma during bone morphogenetic protein 2-induced adipogenesis[J]. Mol Biol Cell, 2003,14(2):545-555.
26. Spiegelman B M, Choy L, Hotamisligil G S, et al. Regulation of adipocyte gene expression in diffenentiation and syndromes of obesity/diabetes[J]. Journal of Biological Chemistry, 1993,268 (10):6823-6826.
27. Spiegelman B M, Flier J S. Adipogenesis and obesity; rounding out the big picture[J]. Cell, 1996,87(3):377-389.
28. Boutros R, Doziers C, Ducommum B. The when and wheres of CDC25 phosphatases[J]. Curr Opin Cell Biol, 2006,18(2):185-191.
29. Aouadi M, Laurent K, Prot M, et al. Inhibition of p38MAPK increases adipogenesis from embryonic to adult stages[J]. Diabetes, 2006,55(2):281-289.
30. Xiong Y, Collins Q F, Lupo J G, et al. p38 mitogen-activated protein kinase plays an inhibitory role in hepatic lipogenesis[J]. J Biol Chem, 2006, [Epub ahead of print].
31. Sweeney G, Sornwar R, Ramlal T, et al. An inhibitor of p38 mitogen-activated protein kinase prevents insulin- stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes[J]. J Biol Chem, 1999,274(15):10071-10078.
32. Suzuki T, Hiroki A, Watanabe T, et al. Potentiation of insulin-related signal transduction by a novel protein-tyrosine phosphatase inhibitor, Et-3,4-dephostatin, on cultured 3T3-L1 adipocytes[J]. J Biol Chem, 2001,276(29):27511-27518.
33. Konrad D, Bilan P J, Nawaz Z, et al. Need for GLUT4 activation to reach maximum effect of insulin-mediated glucose uptake in brown adipocytes isolated from GLUT4myc-expressing mice[J]. Diabetes, 2002,51(9):2719-2726.
34. Somwar R, Koterski S, Sweeney G, et al. A dominant-negative p38 MAPK mutant and novel selective inhibitors of p38 MAPK reduce insulin-stimulated glucose uptake in 3T3-L1 adipocytes without affecting GLUT4 translocation[J]. J Biol Chem, 2002,277 (52):50386-50395.
35. Bazuine M, Carlotti F, Rabelink M J, et al. The p38 mitogen-activated protein kinase inhibitor SB203580 reduces glucose turnover by the glucose transporter-4 of 3T3-L1 adipocytes in the insulin-stimulated state[J]. Endocrinology, 2005,146(4):1818-1824.
36. Bazuine M, Ouwens D M, Gomes de Mesquita D S, et al. Arsenite stimulated glucose transport in 3T3-L1 adipocytes involves both Glut4 translocation and p38 MAPK activity[J]. Eur J Biochem, 2003,270(19):3891-3903.
37. Kayali A G, Austin D A, Webster N J. Stimulation of MAPK cascades by insulin and osmotic shock: lack of an involvement of p38 mitogen-activated protein kinase in glucose transport in 3T3-L1 adipocytes[J]. Diabetes, 2000,49(11):1783-1793.
38. Fujishiro M, Gotoh Y, Katagiri H, et al. MKK6/3 and p38 MAPK pathway activation is not necessary for insulin- induced glucose uptake but regulates glucose transporter expression[J]. J Biol Chem, 2001,276(23):19800-19806.
39. Carlson C J, Rondinone C M. Pharmacological inhibition of p38 MAP kinase results in improved glucose uptake in insulin-resistant 3T3-L1 adipocytes[J]. Metabolism, 2005,54(7):895-901.
40. Ribe D, Yang J, Patel S, et al. Endofacial competitive inhibition of glucose transporter-4 intrinsic activity by the mitogen-activated protein kinase inhibitor SB203580[J]. Endocrinology, 2005,146 (4):1713-1717.
41. Carlson C J, Koterski S, Sciotti R J, et al. Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulalion of GLUT4 expression[J]. Diabetes, 2003,52(3):634-641.
42. Valladares A, Roncero C, Benito M, et al. TNF-alpha inhibits UCP-1 expression in brown adipocytes via ERKs. Opposite effect of p38MAPK[J]. FEBS Lett, 2001,493(1):6-11.
43. Teruel T, Hernandez R, Benito M, et al. Rosiglitazone and retinoic acid induce uncoupling protein-1 (UCP-1) in a p38 mitogen-activated protein kinase-dependent manner in fetal primary brown adipocytes[J]. J Biol Chem, 2003,278(1):263-269.
44. Xue B, Coulter A, Rim J S, et al. Transcriptional synergy and the regulation of Ucp1 during brown adipocyte induction in white fat depots[J]. Mol Cell Biol, 2005,25(15):8311-8322.
45. Kramer D K, Al-Khalili L, Perrini S, et al. Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor delta[J]. Diabetes, 2005, 54(4):1157-1163.
46. Richter E A, Nielsen J N, Jorgensen S B, et al. Exercise signalling to glucose transport in skeletal muscle[J]. Proc Nutr Soc, 2004,63(2):211-216.
47. Turban S, Beardmore V A, Carr J M, et al. Insulin-stimulated glucose uptake does not require p38 mitogen-activated protein kinase in adipose tissue or skeletal muscle[J]. Diabetes, 2005,54 (11):3161-3168.
48. Geiger P C, Wright D C, Han D H, et al. Activation of p38 MAP kinase enhances sensitivity of muscle glucose transport to insulin [J]. Am J Physiol Endocrinol Metab, 2005,288(4):E782-788.
49. McGee S L, Hargreaves M. Exercise and myocyte enhancer factor 2 regulation in human skeletal muscle[J]. Diabetes, 2004,53(5):1208-1214.
50. McGee S L, Hargreaves M. Exercise and skeletal muscle glucose transporter 4 expression: molecular mechanisms[J]. Clin Exp Pharmacol Physiol, 2006,33(4):395-399.
51. de Alvaro C, Teruel T, Hernandez R, et al. Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner[J]. J Biol Chem, 2004,279(17):17070- 17078.
52. Lim J H, Lee J I, Suh Y H, et al. Mitochondrial dysfunction induces aberrant insulin signalling and glucose utilisation in murine C2C12 myotube cells[J]. Diabetologia, 2006,49(8):1924-1936.
53. Lluis F, Perdiguero E, Nebreda A R, et al. Regulation of skeletal muscle gene expression by p38 MAP kinases[J]. Trends Cell Biol, 2006,16(1):36-44.
54. Cuenda A, Cohen P. Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis [J]. J Biol Chem, 1999,274(4):4341-4346.
55. Zetser A, Gredinger E, Bengal E. p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor[J]. J Biol Chem, 1999,274 (8):5193-5200.
56. Wu Z, Woodring P J, Bhakta K S, et al. p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps[J]. Mol Cell Biol, 2000,20(11):3951-3964.
57. Li Y, Jiang B, Ensign W Y, et al. Myogenic differentiation requires signalling through both phosphatidylinositol 3-kinase and p38 MAP kinase[J]. Cell Signal, 2000,12(11-12):751-757.
58. Suelves M, Lluis F, Ruiz V, et al. Phosphorylation of MRF4 transactivation domain by p38 mediates repression of specific myogenic genes[J]. Embo J, 2004,23(2):365-375.
59. Hanson-Painton O, Griffin M, Tang J. Involvement of a cytosolic carrier protein fraction in the microsomal metabolism of benzo(a) pyrene in rat liver[J]. Cancer Res, 1983,43(9):4198-4206.
60. Ornatsky O I, Cox D M, Tangirala P, et al. Post-translational control of the MEF2A transcriptional regulatory protein[J]. Nucleic Acids Res, 1999,27(13):2646-2654.
61. Lluis F, Ballestar E, Suelves M, et al. E47 phosphorylation by p38 MAPK promotes MyoD/E47 association and muscle-specific gene transcription[J]. Embo J, 2005,24(5):974-984.
62. Simone C, Forcales S V, Hill D A, et al. p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci [J]. Nat Genet, 2004,36(7):738-743.
63. Weston A D, Sampaio A V, Ridgeway A G, et al. Inhibition of p38 MAPK signaling promotes late stages of myogenesis[J]. J Cell Sci, 2003,116(Pt 14):2885-2893.
64. Li Y P, Chen Y, John J, et al. TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle[J]. Faseb J, 2005,19(3):362-370.
65. Puigserver P, Wu Z, Park C, et al. A cold-inducible coactivator of of nuclear receptors linked to adaptive thermogenesis [J]. Cell, 1998,92(6):829-839.
66. Lin J, Wu H, Tarr P T, et al. 2002 Transcriptional co-activator PGC-1 alpha drives the formation of slow- twitch muscle fibres[J]. Nature, 418(6899):797-801.
67. Akimoto T, Pohnert S C, Li P, et al. Exercise stimulates Pgc-1alpha transcription in skeletal muscle through activation of the p38 MAPK pathway[J]. J Biol Chem, 2005,280(20):19587-19593.
68. Handschin C, Rhee J, Lin J, et al. An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle[J]. Proc Natl Acad Sci USA, 2003,100 (12):7111-7116.
69. Puigserver P, Rhee J, Lin J, et al. Cytokine Stimulation of Energy Expenditure through p38 MAP Kinase Activation of PPAR Coactivator-1[J]. Molecular Cell, 2001,8(5):971-982.
70. Macfarlane W, Smith S B, James R F, et al. The p38/reactivating kinase mitogen-activated protein kinase cascade mediates the activation of the transcription factor insulin upstream factor 1 and insulin gene transcription by high glucose in pancreatic-cells[J]. J Biol Chem, 1997,272(33):20936-20944.
71. Macfarlane W M, McKinnon C M, Felton-Edkins Z A, et al. Glucose stimulates translocation of the homeodomain transcription factor PDX1 from the cytoplasm to the nucleus in pancreatic beta-cells [J]. J Biol Chem, 1999,274(2):1011-1016.
72. Wu H, MacFarlane W M, Tadayyon M, et al. Insulin stimulates pancreatic-duodenal homoeobox factor-1 (PDX1) DNA- binding activity and insulin promoter activity in pancreatic beta cells[J]. Biochem J, 1999,344 Pt 3:813-818.
73. Rafiq I, da Silva Xavier G, Hooper S, et al. Glucose-stimulated preproinsulin gene expression and nuclear trans-location of pancreatic duodenum homeobox-1 require activation of phosphatidylinositol 3-kinase but not p38 MAPK/SAPK2[J]. J Biol Chem, 2000, 275(21):15977-15984.
74. Kemp D M, Habener J F. Insulinotropic hormone glucagon-like peptide 1 (GLP-1) activation of insulin gene promoter inhibited by p38 mitogen-activated protein kinase[J]. Endocrinology, 2001,142(3):1179-1187.
75. Ando H, Kurita S, Takamura T. The specific p38 mitogen-activated protein kinase pathway inhibitor FR167653 keeps insulitis benign in nonobese diabetic mice[J]. Life Sci, 2004,74(14): 1817-1827.
76. Rhodes C J. Type 2 diabetes-a matter of beta-cell life and death? [J]. Science, 2005,307(5708):380-384.
77. Larsen C M, Wadt K A, Juhl L F, et al. Interleukin-1 beta-induced rat pancreatic islet nitric oxide synthesis requires both the p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases[J]. J Biol Chem, 1998,273(24):15294-15300.
78. Paraskevas S, Aikin R, Maysinger D, et al. Modulation of JNK and p38 stress activated protein kinases in isolated islets of Langerhans: insulin as an autocrine survival signal[J]. Ann Surg, 2001, 233(1):124-133.
79. Saldeen J, Lee J C, Welsh N. Role of p38 mitogen-activated protein kinase (p38 MAPK) in cytokine-induced rat islet cell apoptosis[J]. Biochem Pharmacol, 2001,61(12):1561-1569.
80. Zhang S, Liu H, Liu J, et al. Activation of activating transcription factor 2 by p38 MAP kinase during apoptosis induced by human amylin in cultured pancreatic beta-cells[J]. FEBS J, 2006,273 (16):3779-3791.
81. Cnop M, Welsh N, Jonas J C, et al. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities[J]. Diabetes, 2005,54 (Suppl 2):S97-107.
82. Ehses J A, Casilla V R, Doty T, et al. Glucose-dependent insulinotropic polypeptide promotes beta-(INS-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogen-activated protein kinase[J]. Endocrinology, 2003,144(10):4433-4445.
83. Khoo S, Cobb M H. Activation of mitogen-activating protein kinase by glucose is not required for insulin secretion[J]. Proc Natl Acad Sci USA, 1997,94(11):5599-5604.
84. Burns C J, Howell S L, Jones P M, et al. The p38 mitogen-activated protein kinase cascade is not required for the stimulation of insulin secretion from rat islets of Langerhans[J]. Mol Cell Endocrinol, 1999,148(1-2):29-35.
85. Kuma Y, Campbell D G, Cuenda A. Identification of glycogen synthase as a new substrate for stress-activated protein kinase 2b/p38beta[J]. Biochem J, 2004,379(Pt 1):133-139.
86. Qiao L, Macdougald O A, Shao J. C/EBPalpha mediates induction of hepatic phosphoenolpyruvate carboxykinase by p38 mitogen-activated protein kinase[J]. J Biol Chem, 2006,281(34):24390-24397.
87. Wu J J, Roth R J, Anderson E J, et al. Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity[J]. Cell Metab, 2006,4(1):61-73.
88. Heraig S, Long F, Jhala U S, et al. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1[J]. Nature, 2001,413 (6852):179-183.
89. Feifel E, Obexer P, Andratsch M, et al. p38 MAPK mediates acid-induced transcription of PEPCK in LLC-PK(1)-FBPase(+) cells[J]. Am J Physiol Renal Physiol, 2002,283(4):F678-688.
90. Barger P M, Browning A C, Garner A N, et al. p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor alpha: a potential role in the cardiac metabolic stress response[J]. J Biol Chem, 2001,276(48):44495-44501.
91. Au W S, Kung H F, Lin M C. Regulation of microsomal triglyceride transfer protein gene by insulin in HepG2 cells: roles of MAP-Kerk and MAPKp38[J]. Diabetes, 2003,52(5):1073-1080.
92. Allister E M, Borradaile N M, Edwards J Y, et al. Inhibition of microsomal triglyceride transfer protein expression and apolipoprotein B100 secretion by the citrus flavonoid naringenin and by insulin involves activation of the mitogen-activated protein kinase pathway in hepatocytes[J]. Diabetes, 2005,54(6):1676-1683.
93. Singh R P, Dhawan P, Golden C, et al. One-way cross-talk between p38 (MAPK) and p42/44 (MAPK). Inhibition of p38 (MAPK) induces low density lipoprotein receptor expression through activation of the p42/44 (MAPK) cascade[J]. J Biol Chem, 1999,274(28):19593-19600.
94. Mehta K D, Miller L. Inhibition of stress-activated p38 mitogen-activated protein kinase induces low-density lipoprotein receptor expression[J]. Trends Cardiovasc Med, 1999,9(7):201-205.
95. Kurz A K, Graf D, Schmitt M, et al. Tauroursodesoxycholate-induced choleresis involves p38 (MAPK) activation and translocation of the bile salt export pump in rats[J]. Gastroenterology, 2001, 121(2):407-419.
96. Kubitz R, Sutfels G, Kuhlkamp T, et al. Trafficking of the bile salt export pump from the Golgi to the canalicular membrane is regulated by the p38 MAP kinase[J]. Gastroenterology, 2004,126 (2):541-553.
97. Haussinger D, Graf D, Weiergraber O H. Glutamine and cell signaling in liver[J]. J Nutr, 2001,131(9 Suppl):2509S-14S; discussion 2523S-2524S.
98. Engel F B, Schebesta M, Duong M T, et al. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes [J]. Genes Dev, 2005,19(10):1175-1187.
99. Nemoto S, Sheng Z, Lin A. Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy[J]. Mol Cell Biol, 1998,18(6):3518-3526.
100. Yue T L, Gu J L, Wang C, et al. Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy [J]. J Biol Chem, 2000,275(48):37895-37901.
101. Liao P, Georgakopoulos D, Kovacs A, et al. The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardlomyopathy[J]. Proc Natl Acad Sci USA, 2001,98(21):12283-12288.
102. Zhang S, Weinheimer C, Courtois M, et al. The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis [J]. J Clin Invest, 2003,111(6):833-841.
103. Montessuit C, Rosenblatt-Velin N, Papageorgiou I, et al. Regulation of glucose transporter expression in cardiac myocytes: p38 MAPK is a strong inducer of GLUT4[J]. Cardiovasc Res, 2004, 64(1):94-104.
104. Marais E, Genade S, Huisamen B, et al. Activation of p38 MAPK induced by a multi-cycle ischaemic preconditioning protocol is associated with attenuated p38 MAPK activity during sustained ischaemia and reperfusion[J]. J Mol Cell Cardiol, 2001, 33:769-778.
105. Li D, Williams V, Liu L, et al. LOX-1 inhibition in myocardial ischemia-reperfusion injury: modulation of MMP-1 and inflammation[J]. Am J Physiol Heart Circ Physiol, 2002,283(5):H1795-1801.
106. Gao F, Yue T L, Shi D W, et al. p38 MAPK inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of PMN accumulation[J]. Cardiovasc Res, 2002,53(2):414-422.
107. Zheng M, Reynolds C, Jo S H, et al. Intracellular acidosis-activated p38 MAPK signaling and its essential role in cardiomyocyte hypoxic injury[J]. Faseb J, 2005,19(1):109-111.
108. Weinbrenner C, Liu G S, Cohen M V, et al. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart[J]. J Mol Cell Cardiol, 1997,29(9):2383- 2391.
109. Nakano A, Cohen M V, Critz S, et al. SB 203580, an inhibitor of p38 MAPK, abolishes infarct-limiting effect of ischemic preconditioning in isolated rabbit hearts[J]. Basic Res Cardiol, 2000, 95(6):466-471.
110. Mocanu M M, Baxter G F, Yue Y, et al. The p38 MAPK inhibitor, SB203580, abrogates ischaemic preconditioning in rat heart but timing of administration is critical[J]. Basic Res Cardiol, 2000,95(6):472-478.
111. Nakano A, Baines C P, Kim S O, et al. Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK[J]. Circ Res, 2000,86(2):144-151.
112. Zhao T C, Taher M M, Valerie K C, et al. p38 Triggers late preconditioning elicited by anisomycin in heart; involvement of NF-kappaB and iNOS[J]. Circ Res, 2001,89(10):915-922.
113. Sanada S, Kitakaze M, Papst P J, et al. Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart[J]. Circ Res, 2001,88(2):175-180.
114. Zhao T C, Hines D S, Kukreja R C. Adenosine-induced late preconditioning in mouse hearts: role of p38 MAP kinase and mitochondrial K(ATP) channels[J]. Am J Physiol Heart Circ Physiol, 2001,280(3):H1278-1285.
115. Marais E, Genade S, Strijdom H, et al. p38 MAPK activation triggers pharmacologically-induced beta-adrenergic preconditioning, but not ischaemic preconditioning[J]. J Mol Cell Cardiol, 2001,33(12):2157-2177.
116. Schulz R, Belosjorow S, Gres P, et al. p38 MAP kinase is a mediator of ischemic preconditioning in pigs [J]. Cardiovasc Res, 2002,55(3):690-700.
117. Lochner A, Genade S, Hattingh S, et al. Comparison between ischaemic and anisomycin-induced preconditioning; role of p38 MAPK[J]. Cardiovasc Drugs Ther, 2003,17(3):217-230.
118. Das S, Tosaki A, Bagchi D, et al. Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling[J]. J Pharmacol Exp Ther, 2006,317(3):980-988.
119. Schulz R, Gres P, Skyschally A, et al. Ischemic preconditioning preserves connexin 43 phosphorylation during sustained ischemia in pig hearts in vivo[J]. Faseb J, 2003,17(10):1355-1357.
120. Martindale J J, Wall J A, Martinez-Longoria D M, et al. Overexpression of mitogen-activated protein kinase kinase 6 in the heart improves functional recovery from ischemia in vitro and protects against myocardial infarction in vivo[J]. J Biol Chem, 2005,280 (1):669-676.
121. Kaiser R A, Lyons J M, Duffy J Y, et al. Inhibition of p38 reduces myocardial infarction injury in the mouse but not pig after ischemia- reperfusion[J]. Am J Physiol Heart Circ Physiol, 2005,289:H2747-2751.
122. Witztum J L, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis[J]. J Clin Invest, 1991,88(6):1785-1792.
123. Plutzky J, Viberti G, Haffner S. Atherosclerosis in type 2 diabetes mellitus and insulin resistance: mechanistic links and therapeutic targets[J]. J Diabetes Complications, 2002,16(6):401-415.
124. Plutzky J. Inflammation in atherosclerosis and diabetes mellitus [J]. Rev Endocr Metab Disord, 2004,5(3):255-259.
125. Stern M P. Diabetes and cardiovascular disease. The "common soil" hypothesis[J]. Diabetes, 1995,44(4):369-374.
126. Wang G, Siow Y L, O K. Homocysteine stimulates nuclear factor kappaB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells; a possible role for protein kinase C[J]. Biochem J, 2000,352(Pt 3):817-826.
127. Poddar R, Sivasubramanian N, DiBello P M, et al. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease[J]. Circulation, 2001,103(22):2717-2723.
128. Sung F L, Slow Y L, Wang G, et al. Homocysteine stimulates the expression of monocyte chemoattractant protein-1 in endothelial cells leading to enhanced monocyte chemotaxis[J]. Mol Cell Biochem, 2001,216(1-2):121-128.
129. Olson T S, Ley K. Chemokines and chemokine receptors in leukocyte trafficking[J]. Am J Physiol Regul Integr Comp Physiol, 2002,283(1):R7-28.
130. Goebeler M, Kilian K, Gillitzer R, et al. The MKK6/p38 stress kinase cascade is critical for tumor necrosis factor-alpha-induced expression of monocyte-chemoattractant protein-1 in endothelial cells[J]. Blood, 1999,93(3):857-865.
131. Marin V, Farnarier C, Gres S, et al. The p38 mitogen-activated protein kinase pathway plays a critical role in thrombin-induced endothelial chemokine production and leukocyte recruitment [J]. Blood, 2001,98(3):667-673.
132. Zeng X, Dai J, Remick D G, et al. Homocysteine mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes[J]. Circ Res, 2003,93(4):311-320.
133. Domoto K, Taniguchi T, Takaishi H, et al. Chylomicron remnants induce monocyte chemoattractant protein-1 expression via p38 MAPK activation in vascular smooth muscle cells[J]. Atherosclerosis, 2003,171(2):193-200.
134. Suzuki E, Salonaka H, Nishimatsu H, et al. Myocyte enhancer factor 2 mediates vascular inflammation via the p38-dependent pathway[J]. Circ Res, 2004,95(1):42-49.
135. Matsuyama W, Wang L, Farrar W L, et al. Activation of discoidin domain receptor 1 isoform b with collagen up-regulates chemokine production in human macrophages: role of p38 mitogen-activated protein kinase and NF-kappa B[J]. J Immunol, 2004,172 (4):2332-2340.
136. Cambien B, Pomeranz M, Millet M A, et al. Signal transduction involved in MCP-1-mediated monocytic transendothelial migration [J]. Blood, 2001,97(2):359-366.
137. Ashida N, Arai H, Yamasaki M, et al. Distinct signaling pathways for MCP-1-dependent integrin activation and chemotaxis[J]. J Biol Chem, 2001,276(19):16555-16560.
138. Dubois P M, Palmer D, Webb M L, et al. Early signal transduction by the receptor to the chemokine monocyte chemolactic protein-1 in a murine T cell hybrid [J]. J Immunol, 1996,156(4):1356-1361.
139. Vitale S, Schmid-Alliana A, Breuil V, et al. Soluble fractalkine prevents monocyte chemoattractant protein-1-induced monocyte migration via inhibition of stress-activated protein kinase 2/p38 and matrix metalloproteinase activities[J]. J Immunol, 2004, 172(1):585-592.
140. Matsuyama W, Kamohara H, Galligan C, et al. Interaction of discoidin domain receptor 1 isoform b (DDR1b) with collagen activates p38 mitogen-activated protein kinase and promotes differentiation of macrophages[J]. Faseb J, 2003,17(10):1286-1288.
141. McGinn S, Saad S, Poronnik P, et al. High glucose-mediated effects on endothelial cell proliferation occur via p38 MAP kinase [J]. Am J Physiol Endocrinol Metab, 2003,285(4):E708-717.
142. McMullen M E, Bryant P W, Glembotski C C, et al. Activation of p38 has opposing effects on the proliferation and migration of endothelial cells[J]. J Biol Chem, 2005,280(22):20995-21003.
143. Shen Y H, Zhang L, Gan Y, et al. Up-regulalion of PTEN (phosphatase and tensin homolog deleted on chromosome ten) mediates p38 MAPK stress signal-induced inhibition of insulin signaling. A cross-talk between stress signaling and insulin signaling in resistin-treated human endothelial cells[J]. J Biol Chem, 2006,281(12):7727-7736.
144. Seeger F H, Haendeler J, Walter D H, et al. p38 mitogen-activated protein kinase downregulates endothelial progenitor cells[J]. Circulation, 2005,111(19):1184-1191.
145. Zhan Y, Kim S, Izumi Y, et al. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression[J]. Arterioscler Thromb Vasc Biol, 2003,23(5):795-801.
146. 2 and PDGF in mesangial cells[J]. Am J Physiol Renal Physiol, 2002, 282(3):F485-491.
147. Igarashi M, Takeda Y, Ishibashi N, et al. Pioglitazone reduces smooth muscle cell density of rat carotid arterial intima induced by balloon catheterization[J]. Horm Metab Res, 1997,29(9):444-449.
148. Yamaguchi H, Igarashi M, Hirata A, et al. Altered PDGF-BB-induced p38 MAP kinase activation in diabetic vascular smooth muscle cells: roles of protein kinase C-delta[J]. Arterioscler Thromb Vasc Biol, 2004,24(11):2095-2101.
149. Dobreva I, Zschornig O, Waeber G, et al. Cholesterol is the major component of native lipoproteins activating the p38 mitogen-activated protein kinases[J]. Biol Chem, 2005,386(9):909-918.
150. Surapisitchat J, Hoefen R J, Pi X, et al. Fluid shear stress inhibits TNF-alpha activation of JNK but not ERK1/2 or p38 in human umbilical vein endothelial cells: Inhibitory crosstalk among MAPK family members [J]. Proc Natl Acad Sci USA, 2001,98(11):6476-6481.
151. Ju H, Behm D J, Nerurkar S, et al. p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 1. p38 MAPK-dependent endothelial dysfunction and hypertension [J]. J Pharmacol Exp Ther, 2003,307(3):932-938.
152. Paris D, Town T, Humphrey J, et al. Cholesterol modulates vascular reactivity to endothelin-1 by stimulating a pro-inflammatory pathway[J]. Biochem Biophys Res Commun, 2000,274(2): 553-558.
153. Yamboliev I A, Hedges J C, Mutnick J L, et al. Evidence for modulation of smooth muscle force by the p38 MAP kinase/HSP27 pathway[J]. Am J Physiol Heart Circ Physiol, 2000,278(6):H1899-1907.
154. Muller E, Burger-Kentischer A, Neuhofer W, et al. Possible involvement of heat shock protein 25 in the angiotensin II-induced glomerular mesangial cell contraction via p38 MAP kinase[J]. J Cell Physiol, 1999,181(3):462-469.
155. Meloche S, Landry J, Huot J, et al. p38 MAP kinase pathway regulates angiotensin II-induced contraction of rat vascular smooth muscle[J]. Am J Physiol Heart Circ Physiol, 2000,279(2):H741-751.
156. Ohanian J, Cunliffe P, Ceppi E, et al. Activation of p38 mitogen-activated protein kinases by endothelin and noradrenaline in small arteries, regulation by calcium influx and tyrosine kinases, and their role in contraction[J]. Arterioscler Thromb Vase Biol, 2001,21(12):1921-1927.